These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28086884)

  • 1. Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.
    Kahnert K; Lucke T; Biertz F; Lechner A; Watz H; Alter P; Bals R; Behr J; Holle R; Huber RM; Karrasch S; Stubbe B; Wacker M; Söhler S; Wouters EF; Vogelmeier C; Jörres RA;
    Respir Res; 2017 Jan; 18(1):14. PubMed ID: 28086884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
    Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pattern and severity of respiratory muscle weakness on carbon monoxide gas transfer and lung volumes.
    Hart N; Cramer D; Ward SP; Nickol AH; Moxham J; Polkey MI; Pride NB
    Eur Respir J; 2002 Oct; 20(4):996-1002. PubMed ID: 12412695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.
    Trudzinski FC; Kahnert K; Vogelmeier CF; Alter P; Seiler F; Fähndrich S; Watz H; Welte T; Speer T; Zewinger S; Biertz F; Kauczor HU; Jörres RA; Bals R;
    Respir Med; 2019; 154():18-26. PubMed ID: 31203096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
    Kahnert K; Lucke T; Huber RM; Behr J; Biertz F; Vogt A; Watz H; Alter P; Fähndrich S; Bals R; Holle R; Karrasch S; Söhler S; Wacker M; Ficker JH; Parhofer KG; Vogelmeier C; Jörres RA;
    PLoS One; 2017; 12(5):e0177501. PubMed ID: 28505167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary function in chronic heart failure. Changes after heart transplantation.
    Ulrik CS; Carlsen J; Arendrup H; Aldershvile J
    Scand Cardiovasc J; 1999; 33(3):131-6. PubMed ID: 10399799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment.
    Kahnert K; Andreas S; Kellerer C; Lutter JI; Lucke T; Yildirim Ö; Lehmann M; Seissler J; Behr J; Frankenberger M; Bals R; Watz H; Welte T; Trudzinski FC; Vogelmeier CF; Alter P; Jörres RA;
    Sci Rep; 2022 Jan; 12(1):1435. PubMed ID: 35082306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion capacity of the lung for carbon monoxide - A potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease?
    Weinreich UM; Thomsen LP; Brock C; Karbing DS; Rees SE
    Chron Respir Dis; 2015 Nov; 12(4):357-64. PubMed ID: 26323278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of lung volumes using body plethysmography and helium dilution methods in COPD patients: a correlation and diagnosis analysis.
    Tang Y; Zhang M; Feng Y; Liang B
    Sci Rep; 2016 Nov; 6():37550. PubMed ID: 27876834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline.
    Karch A; Vogelmeier C; Welte T; Bals R; Kauczor HU; Biederer J; Heinrich J; Schulz H; Gläser S; Holle R; Watz H; Korn S; Adaskina N; Biertz F; Vogel C; Vestbo J; Wouters EF; Rabe KF; Söhler S; Koch A; Jörres RA;
    Respir Med; 2016 May; 114():27-37. PubMed ID: 27109808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-breathing vs single-breath TLCO in patients with unequal ventilation and diffusion.
    Jansons H; Fokkens JK; van der Tweel I; Kreukniet J
    Respir Med; 1998 Jan; 92(1):18-24. PubMed ID: 9519219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET.
    Kahnert K; Föhrenbach M; Lucke T; Alter P; Trudzinski FT; Bals R; Lutter JI; Timmermann H; Söhler S; Förderreuther S; Nowak D; Watz H; Waschki B; Behr J; Welte T; Vogelmeier CF; Jörres RA
    Respir Res; 2020 Jan; 21(1):28. PubMed ID: 31959163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of changes in carbon monoxide transfer factor in men with chronic obstructive pulmonary disease.
    Osmanliev DP; Joyce H; Watson RA; Pride NB
    Respir Med; 2005 Aug; 99(8):1053-60. PubMed ID: 15950148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.
    Wacker ME; Jörres RA; Karch A; Koch A; Heinrich J; Karrasch S; Schulz H; Peters A; Gläser S; Ewert R; Baumeister SE; Vogelmeier C; Leidl R; Holle R;
    Respir Res; 2016 Jul; 17(1):81. PubMed ID: 27405652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired diffusion at submaximal lung inflation in asthma and copd patients.
    Verbanck S; Hughes M
    Respir Physiol Neurobiol; 2024 Oct; 328():104304. PubMed ID: 39096947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET.
    Kahnert K; Jörres RA; Lucke T; Trudzinski FC; Mertsch P; Bickert C; Ficker JH; Behr J; Bals R; Watz H; Welte T; Vogelmeier CF; Alter P;
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3189-3199. PubMed ID: 34853511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].
    Buchmann N; Norman K; Steinhagen-Thiessen E; Demuth I; Eckardt R
    Z Gerontol Geriatr; 2016 Jul; 49(5):405-15. PubMed ID: 26508109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.